Follow the GENOMIC HEALTH INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €12.3m. The latest transaction was filed on 11 February 2016 (Levée d'options). Among the most active insiders: BAKER FELIX. The full history is openly available.
21
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
6 ops.
Sell Volume
Fundamental score
Ranked 28,254 of 29,062 companies
11.9
score / 100
Value
1
Quality
23
FCF yld-133%
Earn yld·
EV/EBITDA·
ROE-74%
Gross mgn46%
Net mgn-93%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
GENOMIC HEALTH INC is a genomic diagnostics company that provides tests to assist in clinical decision-making for cancer treatment. It is listed on the XNAS market.